Related Experiment Video
Updated: Aug 19, 2026
Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
Published on: June 24, 2022
Insights
Hepatoblastoma, a rare liver cancer, occurred in siblings. High platelet counts in affected infants may indicate intra-tumoral platelet production, warranting monitoring of at-risk siblings.
Area of Science:
- Pediatric Oncology
- Hepatobiliary Medicine
- Cancer Genetics
Background:
- Hepatoblastoma is a rare malignant liver tumor primarily affecting infants and young children.
- Familial clustering of hepatoblastoma is exceptionally rare, with limited documented cases.
Observation:
- Two siblings presented with hepatoblastoma, one with motor retardation and the other with microcephaly and undescended testis.
- Both infants exhibited marked thrombocytosis (high platelet counts) prior to surgical intervention.
Findings:
- The presence of numerous megakaryocytes within the hepatoblastomas suggests potential intra-tumoral platelet production.
- While iron deficiency could contribute to thrombocytosis, it doesn't fully explain the observed levels.
Implications:
- This case highlights the possibility of familial hepatoblastoma, even across different sexes.
- Periodic clinical and laboratory surveillance is recommended for siblings at risk of developing hepatoblastoma.
Abstract:
Two infants, a sister with motor retardation and brother with slight microcephaly and an undescended testis, died of hepatoblastoma. Only another documented familial occurrence of this tumor, affecting siblings of the same sex, can be found in the literature. The two patients described in this paper exhibited high platelet counts prior to liver resection. Although iron deficiency may have contributed to the thrombocytosis, the finding of many megakariocytes within the hepatoblastomas suggests an intra-tumoral production of platelets. An epidemiological investigation of the family under study failed to yield conclusive data. Hepatoblastoma is a rare tumor, but it may affect more than one sibling. Therefore, periodic clinical and laboratory evaluations of the siblings at risk appear to be justified.
